Wim Oyen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Rats
Mice

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Lütje Susanne; de Rooy Jacky W J; Croockewit Sandra; Koedam Emmeline; Oyen Wim J G; Raymakers Reinier A
Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
Vriens Dennis; van Laarhoven Hanneke W M; van Asten Jack J A; Krabbe Paul F M; Visser Eric P; Heerschap Arend; Punt Cornelis J A; de Geus-Oei Lioe-Fee; Oyen Wim J G
Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.
Kyrieleis Henriette A C; Löwik Marije M; Pronk Ilse; Cruysberg Hans R M; Kremer Jan A M; Oyen Wim J G; van den Heuvel Bert L P; Wetzels Jack F M; Levtchenko Elena N
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Wim Oyen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lütje Susanne; de Rooy Jacky W J; Croockewit Sandra; Koedam Emmeline; Oyen Wim J G; Raymakers Reinier A
Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
Annals of hematology 2009;88(12):1161-8.
2009: Vriens Dennis; van Laarhoven Hanneke W M; van Asten Jack J A; Krabbe Paul F M; Visser Eric P; Heerschap Arend; Punt Cornelis J A; de Geus-Oei Lioe-Fee; Oyen Wim J G
Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(11):1777-84.
2009: Kyrieleis Henriette A C; Löwik Marije M; Pronk Ilse; Cruysberg Hans R M; Kremer Jan A M; Oyen Wim J G; van den Heuvel Bert L P; Wetzels Jack F M; Levtchenko Elena N
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(10):1593-600.
2009: Oyen Wim J G; van der Graaf Winette T A
Molecular imaging of solid tumors: exploiting the potential.
Nature reviews. Clinical oncology 2009;6(10):609-11.
2009: Bastiaannet Esther; Wobbes Theo; Hoekstra Otto S; van der Jagt Eric J; Brouwers Adrienne H; Koelemij Ron; de Klerk John M H; Oyen Wim J G; Meijer Sybren; Hoekstra Harald J
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4774-80.
2009: Laverman Peter; Meeuwissen Silvie A; van Berkel Sander S; Oyen Wim J G; van Delft Floris L; Rutjes Floris P J T; Boerman Otto C
In-depth evaluation of the cycloaddition--retro-Diels--Alder reaction for in vivo targeting with [(111)In]-DTPA-RGD conjugates.
Nuclear medicine and biology 2009;36(7):749-57.
2009: Ruers Theo J M; Wiering Bastiaan; van der Sijp Joost R M; Roumen Rudi M; de Jong Koert P; Comans Emile F I; Pruim Jan; Dekker Helena M; Krabbe Paul F M; Oyen Wim J G
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(7):1036-41.
2009: van Herpen Carla M L; van der Graaf Winette T A; Oyen Wim J G
Time to target evaluation criteria of targeted therapies.
Nuclear medicine communications 2009;30(7):487-9.
2009: de Jong Gabie M; Hendriks Thijs; Eek Annemarie; Oyen Wim J G; Heskamp Sandra; Bleichrodt Robert P; Boerman Otto C
Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin.
Annals of surgical oncology 2009;16(7):2065-73.
2009: Vriens Dennis; de Geus-Oei Lioe-Fee; van Laarhoven Hanneke W; Timmer-Bonte Johanna N H; Krabbe Paul F M; Visser Eric P; Oyen Wim J G
Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies.
Nuclear medicine communications 2009;30(7):550-7.
2009: Schuurbiers Olga C J; Kaanders Johannes H A M; van der Heijden Henricus F M; Dekhuijzen Richard P N; Oyen Wim J G; Bussink Johan
The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(6):761-7.
2009: Meijer Patrick; Oyen Wim J G; Dekker Douwe; van den Broek Petra H H; Wouters Constatijn W; Boerman Otto C; Scheffer Gert Jan; Smits Paul; Rongen Gerard A
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(6):963-8.
2009: Sikkink Cornelis J J M; Reijnen Michel M P J; Laverman Peter; Oyen Wim J G; van Goor Harry
Tc-99m-PEG-liposomes target both adhesions and abscesses and their reduction by hyaluronate in rats with fecal peritonitis.
The Journal of surgical research 2009;154(2):246-51.
2009: de Geus-Oei Lioe-Fee; Vriens Dennis; van Laarhoven Hanneke W M; van der Graaf Winette T A; Oyen Wim J G
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50 Suppl 1():43S-54S.
2009: Stollman Thamar H; Scheer Marian G W; Franssen Gerben M; Verrijp Kiek N; Oyen Wim J G; Ruers Theo J M; Leenders William P J; Boerman Otto C
Tumor accumulation of radiolabeled bevacizumab due to targeting of cell- and matrix-associated VEGF-A isoforms.
Cancer biotherapy & radiopharmaceuticals 2009;24(2):195-200.
2009: Schuurhuis Danita H; Verdijk Pauline; Schreibelt Gerty; Aarntzen Erik H J G; Scharenborg Nicole; de Boer Annemiek; van de Rakt Mandy W M M; Kerkhoff Marieke; Gerritsen Marie-Jeanne P; Eijckeler Femke; Bonenkamp Johannes J; Blokx Willeke; van Krieken J Han; Boerman Otto C; Oyen Wim J G; Punt Cornelis J A; Figdor Carl G; Adema Gosse J; de Vries I Jolanda M
In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.
Cancer research 2009;69(7):2927-34.
2009: Verdijk Pauline; Aarntzen Erik H J G; Lesterhuis W Joost; Boullart A C Inge; Kok Ellemieke; van Rossum Michelle M; Strijk Simon; Eijckeler Femke; Bonenkamp Johannes J; Jacobs Joannes F M; Blokx Willeke; Vankrieken J Han J M; Joosten Irma; Boerman Otto C; Oyen Wim J G; Adema Gosse; Punt Cornelis J A; Figdor Carl G; de Vries I Jolanda M
Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2531-40.
2009: Schinagl Dominic A X; Hoffmann Aswin L; Vogel Wouter V; van Dalen Jorn A; Verstappen Suzan M M; Oyen Wim J G; Kaanders Johannes H A M
Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(1):95-100.
2009: Krabbendam Ineke; Maas Martje L; Thijssen Dick H J; Oyen Wim J G; Lotgering Fred K; Hopman Maria T E; Spaanderman Marc E A
Exercise-induced changes in venous vascular function in nonpregnant formerly preeclamptic women.
Reproductive sciences (Thousand Oaks, Calif.) 2009;16(4):414-20.
2009: Troost Esther G C; Bussink Johan; Oyen Wim J G; Kaanders Johannes H A M
18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(3):490-1.
2009: Bleeker-Rovers Chantal P; van der Meer Jos W M; Oyen Wim J G
Fever of unknown origin.
Seminars in nuclear medicine 2009;39(2):81-7.
2009: Van Laarhoven Hanneke W M; Vinken Maarten; Mus Roel; Flucke Uta; Oyen Wim J G; Van der Graaf Winette T
The diagnostic hurdle of an elderly male with bone pain: how 18F-FDG-PET led to diagnosis of a leiomyosarcoma of the adrenal gland.
Anticancer research 2009;29(2):469-72.
2009: Aarts Frits; Hendriks Thijs; Eek Annemarie; Oyen Wim J G; Bleichrodt Robert P; Boerman Otto C
Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?
Cancer biotherapy & radiopharmaceuticals 2009;24(1):29-34.
2009: Visser Eric P; Disselhorst Jonathan A; Brom Maarten; Laverman Peter; Gotthardt Martin; Oyen Wim J G; Boerman Otto C
Spatial resolution and sensitivity of the Inveon small-animal PET scanner.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(1):139-47.
2008: Troost Esther G C; Laverman Peter; Kaanders Johannes H A M; Oyen Wim J G; Boerman Otto C; Bussink Johan
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-gluco-RGD autoradiography.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(10):1732; author reply 1732-3.
2008: Troost Esther G C; Laverman Peter; Philippens Mariëlle E P; Lok Jasper; van der Kogel Albert J; Oyen Wim J G; Boerman Otto C; Kaanders Johannes H A M; Bussink Johan
Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
European journal of nuclear medicine and molecular imaging 2008;35(10):1803-11.
2008: Vegt Erik; van Eerd Julliëtte E M; Eek Annemarie; Oyen Wim J G; Wetzels Jack F M; de Jong Marion; Russel Frans G M; Masereeuw Rosalinde; Gotthardt Martin; Boerman Otto C
Reducing renal uptake of radiolabeled peptides using albumin fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1506-11.
2008: Scheer Marian G W; Stollman Thamar H; Boerman Otto C; Verrijp Kiek; Sweep Fred C G J; Leenders William P J; Ruers Theo J M; Oyen Wim J G
Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression.
European journal of cancer (Oxford, England : 1990) 2008;44(13):1835-40.
2008: Truijers Maarten; Kurvers Harrie A J M; Bredie Sebastian J H; Oyen Wim J G; Blankensteijn Jan D
In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2008;15(4):462-7.
2008: Brouwers Adrienne H; Mulders Peter F A; Oyen Wim J G
Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3808-9; author reply 3811-2.
2008: Boerman Otto C; Oyen Wim J G
Multimodality probes: amphibian cars for molecular imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1213-4.
2008: Krabbendam Ineke; Janssen Ben J; Van Dijk Arie P J; Jongsma Henk W; Oyen Wim J G; Lotgering Fred K; Spaanderman Marc E A
The relation between venous reserve capacity and low plasma volume.
Reproductive sciences (Thousand Oaks, Calif.) 2008;15(6):604-12.
2008: Zuijdwijk Marc D; Vogel Wouter V; Corstens Frans H M; Oyen Wim J G
Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
Nuclear medicine communications 2008;29(7):636-41.
2008: Aarts Frits; Hendriks Thijs; Boerman Otto C; Oyen Wim J G; Bleichrodt Robert P
Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin.
Cancer biotherapy & radiopharmaceuticals 2008;23(3):301-9.
2008: Visser Eric P; Philippens Mariëlle E P; Kienhorst Laura; Kaanders Johannes H A M; Corstens Frans H M; de Geus-Oei Lioe-Fee; Oyen Wim J G
Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(6):892-8.
2008: Scheer Marian G W; Stollman Thamar H; Vogel Wouter V; Boerman Otto C; Oyen Wim J G; Ruers Theo J M
Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(6):887-91.
2008: Senft Asaf; de Bree Remco; Hoekstra Otto S; Kuik Dirk J; Golding Richard P; Oyen Wim J G; Pruim Jan; van den Hoogen Frank J; Roodenburg Jan L N; Leemans C René
Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;87(2):221-9.
2008: Stollman Thamar H; Scheer Marian G W; Leenders William P J; Verrijp Kiek C N; Soede Annemieke C; Oyen Wim J G; Ruers Theo J M; Boerman Otto C
Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody.
International journal of cancer. Journal international du cancer 2008;122(10):2310-4.
2008: Aarts Frits; Bleichrodt Robert P; Oyen Wim J G; Boerman Otto C
Intracavitary radioimmunotherapy to treat solid tumors.
Cancer biotherapy & radiopharmaceuticals 2008;23(1):92-107.
2008: Laverman Peter; Roosenburg Susan; Gotthardt Martin; Park Jeseong; Oyen Wim J G; de Jong Marion; Hellmich Mark R; Rutjes Floris P J T; van Delft Floris L; Boerman Otto C
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
European journal of nuclear medicine and molecular imaging 2008;35(2):386-92.
2008: Wiering Bastiaan; Vogel Wouter V; Ruers Theo J M; Oyen Wim J G
Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Digestive surgery 2008;25(6):413-20.
2008: Geus-Oei Lioe-Fee de; Oyen Wim J G
Predictive and prognostic value of FDG-PET.
Cancer imaging : the official publication of the International Cancer Imaging Society 2008;8():70-80.
2007: de Jong Wouter K; van der Heijden Henricus F M; Pruim Jan; Dalesio Otilia; Oyen Wim J G; Groen Harry J M
Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(11):1007-12.
2007: Schinagl Dominic A X; Vogel Wouter V; Hoffmann Aswin L; van Dalen Jorn A; Oyen Wim J; Kaanders Johannes H A M
Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
International journal of radiation oncology, biology, physics 2007;69(4):1282-9.
2007: Aarts F; Hendriks T; Boerman O C; Koppe M J; Oyen W J G; Bleichrodt R P
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Annals of surgical oncology 2007;14(11):3274-82.
2007: de Koning Daan B; Drenth Joost P H; Oyen Wim J G; Wagenaar Michiel; Aliredjo Riena P; Nagengast Fokko M
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: report of a case.
Diseases of the colon and rectum 2007;50(11):1987-91.
2007: Oyen W J G; Bodei L; Giammarile F; Maecke H R; Tennvall J; Luster M; Brans B
Targeted therapy in nuclear medicine--current status and future prospects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1782-92.
2007: Ropela J A; van Die L; Oyen W J G; Rongen G A
Fever and cough in a patient with diabetes. Empyema caused by S. typhimurium.
The Netherlands journal of medicine 2007;65(9):357, 358.
2007: de Geus-Oei Lioe-Fee; van der Heijden Henricus F M; Corstens Frans H M; Oyen Wim J G
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.
Cancer 2007;110(8):1654-64.
2007: de Geus-Oei Lioe-Fee; van der Heijden Henricus F M; Visser Eric P; Hermsen Rick; van Hoorn Bas A; Timmer-Bonte Johanna N H; Willemsen Antoon T; Pruim Jan; Corstens Frans H M; Krabbe Paul F M; Oyen Wim J G
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(10):1592-8.
2007: Dijkgraaf Ingrid; Boerman Otto C; Oyen Wim J G; Corstens Frans H M; Gotthardt Martin
Development and application of peptide-based radiopharmaceuticals.
Anti-cancer agents in medicinal chemistry 2007;7(5):543-51.
2007: Oei Angèle L M; Massuger Leon F A G; Oyen Wim J G
Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer.
Cancer biotherapy & radiopharmaceuticals 2007;22(4):508-14.
2007: Rennen Huub J J M; Laverman Peter; van Eerd Julliëtte E M; Oyen Wim J G; Corstens Frans H M; Boerman Otto C
PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation.
Nuclear medicine and biology 2007;34(6):691-5.
2007: Haaxma Charlotte A; Bloem Bastiaan R; Borm George F; Oyen Wim J G; Leenders Klaus L; Eshuis Silvia; Booij Jan; Dluzen Dean E; Horstink Martin W I M
Gender differences in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2007;78(8):819-24.
2007: Vogel Wouter V; van Dalen Jorn A; Wiering Bas; Huisman Henkjan; Corstens Frans H M; Ruers Theo J M; Oyen Wim J G
Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(6):910-9.
2007: van Dalen Jorn A; Hoffmann Aswin L; Dicken Volker; Vogel Wouter V; Wiering Bastiaan; Ruers Theo J; Karssemeijer Nico; Oyen Wim J G
A novel iterative method for lesion delineation and volumetric quantification with FDG PET.
Nuclear medicine communications 2007;28(6):485-93.
2007: Boerman Otto C; Koppe Manuel J; Postema E J; Corstens Frans H; Oyen Wim J
Radionuclide therapy of cancer with radiolabeled antibodies.
Anti-cancer agents in medicinal chemistry 2007;7(3):335-43.
2007: Troost Esther G C; Vogel Wouter V; Merkx Matthias A W; Slootweg Piet J; Marres Henri A M; Peeters Wenny J M; Bussink Johan; van der Kogel Albert J; Oyen Wim J G; Kaanders Johannes H A M
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(5):726-35.
2007: Riksen Niels P; Franke Barbara; Oyen Wim J G; Borm George F; van den Broek Petra; Boerman Otto C; Smits Paul; Rongen Gerard A
Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene.
European heart journal 2007;28(9):1085-91.
2007: Brans B; Bodei L; Giammarile F; Linden O; Luster M; Oyen W J G; Tennvall J
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
European journal of nuclear medicine and molecular imaging 2007;34(5):772-86.
2007: Bleeker-Rovers Chantal P; Vos Fidel J; Mudde Aart H; Dofferhoff Anton S M; de Geus-Oei Lioe-Fee; Rijnders Anton J; Krabbe Paul F M; Corstens Frans H M; van der Meer Jos W M; Oyen Wim J G
A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.
European journal of nuclear medicine and molecular imaging 2007;34(5):694-703.
2007: van der Eerden A W; den Heijer M; Oyen W J; Hermus A R
Cushing's syndrome and bone mineral density: lowest Z scores in young patients.
The Netherlands journal of medicine 2007;65(4):137-41.
2007: Gotthardt Martin; van Eerd-Vismale Julliëtte; Oyen Wim J G; de Jong Marion; Zhang Hanwen; Rolleman Edgar; Maecke Helmut R; Béhé Martin; Boerman Otto
Indication for different mechanisms of kidney uptake of radiolabeled peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):596-601.
2007: Hoffmann Aswin L; van Dalen Jorn A; Lee John; Grégoire Vincent; Oyen Wim J G; Kaanders Johannes H A M
Regarding Davis et al.: Assessment of (18)F PET signals for automatic target volume definition in radiotherapy treatment planning.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(1):102-3; author reply 103.
2007: Berger Hans J; van der Werf Sieberen P; Horstink Casper A; Cools Alexander R; Oyen Wim J; Horstink Martin W
Writer's cramp: restoration of striatal D2-binding after successful biofeedback-based sensorimotor training.
Parkinsonism & related disorders 2007;13(3):170-3.
2007: Verstappen C C P; Bloem B R; Haaxma C A; Oyen W J G; Horstink M W I M
Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.
European journal of nuclear medicine and molecular imaging 2007;34(4):502-7.
2007: van Dalen Jorn A; Visser Eric P; Vogel Wouter V; Corstens Frans H M; Oyen Wim J G
Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET.
Medical physics 2007;34(3):889-97.
2007: Bleeker-Rovers Chantal P; Rennen Huub J J M; Boerman Otto C; Wymenga Ate B; Visser Eric P; Bakker Johannes H; van der Meer Jos W M; Corstens Frans H M; Oyen Wim J G
99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(3):337-43.
2007: Ruers Theo J M; Joosten Joris J; Wiering Bastiaan; Langenhoff Barbara S; Dekker Heleen M; Wobbes Theo; Oyen Wim J G; Krabbe Paul F M; Punt Cornelis J A
Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
Annals of surgical oncology 2007;14(3):1161-9.
2007: Visser Eric; Postema Ernst; Boerman Otto; Visschers Jeroen; Oyen Wim; Corstens Frans
Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND).
European journal of nuclear medicine and molecular imaging 2007;34(3):413-21.
2007: Vogel Wouter V; van Riel Piet L C M; Oyen Wim J G
FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus.
European journal of nuclear medicine and molecular imaging 2007;34(3):439.
2007: Westerterp Marinke; Pruim Jan; Oyen Wim; Hoekstra Otto; Paans Anne; Visser Eric; van Lanschot Jan; Sloof Gerrit; Boellaard Ronald
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.
European journal of nuclear medicine and molecular imaging 2007;34(3):392-404.
2007: Laverman Peter; Blokx Willeke A M; Te Morsche René H M; Frielink Cathelijne; Boerman Otto C; Oyen Wim J G; Drenth Joost P H
[(18)F]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(2):127-32.
2007: Cuijpers M L H; Vos F J; Bleeker-Rovers C P; Krabbe P F M; Pickkers P; van Dijk A P J; Wanten G J A; Sturm P D; Oyen W J G; Kullberg B J
Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(2):105-13.
2007: Wiering B; Ruers T J M; Krabbe P F M; Dekker H M; Oyen W J G
Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
Annals of surgical oncology 2007;14(2):818-26.
2007: Aarts Frits; Koppe Manuel J; Hendriks Thijs; van Eerd Julliëtte E M; Oyen Wim J G; Boerman Otto C; Bleichrodt Robert P
Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin.
Annals of surgical oncology 2007;14(2):533-40.
2007: Dijkgraaf Ingrid; Kruijtzer John A W; Frielink Cathelijne; Corstens Frans H M; Oyen Wim J G; Liskamp Rob M J; Boerman Otto C
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
International journal of cancer. Journal international du cancer 2007;120(3):605-10.
2007: Wiering B; Krabbe P F M; Dekker H M; Oyen W J G; Ruers T J M
The role of FDG-PET in the selection of patients with colorectal liver metastases.
Annals of surgical oncology 2007;14(2):771-9.
2007: Dijkgraaf Ingrid; Kruijtzer John A W; Liu Shuang; Soede Annemieke C; Oyen Wim J G; Corstens Frans H M; Liskamp Rob M J; Boerman Otto C
Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.
European journal of nuclear medicine and molecular imaging 2007;34(2):267-73.
2007: Bleeker-Rovers Chantal P; Vos Fidel J; de Kleijn Elisabeth M H A; Mudde Aart H; Dofferhoff Ton S M; Richter Clemens; Smilde Tineke J; Krabbe Paul F M; Oyen Wim J G; van der Meer Jos W M
A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.
Medicine 2007;86(1):26-38.
2007: Dijkgraaf Ingrid; Liu Shuang; Kruijtzer John A W; Soede Annemieke C; Oyen Wim J G; Liskamp Rob M J; Corstens Frans H M; Boerman Otto C
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
Nuclear medicine and biology 2007;34(1):29-35.
2007: de Geus-Oei Lioe-Fee; van Krieken J Han J M; Aliredjo Riena P; Krabbe Paul F M; Frielink Cathelijne; Verhagen Ad F T; Boerman Otto C; Oyen Wim J G
Biological correlates of FDG uptake in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):79-87.
2007: Stillebroer Alexander B; Oosterwijk Egbert; Oyen Wim J G; Mulders Peter F A; Boerman Otto C
Radiolabeled antibodies in renal cell carcinoma.
Cancer imaging : the official publication of the International Cancer Imaging Society 2007;7():179-88.
2007: van Dalen Jorn A; Vogel Wouter V; Corstens Frans H M; Oyen Wim J G
Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations.
Cancer imaging : the official publication of the International Cancer Imaging Society 2007;7():77-83.
2007: Kristinsson Jón O; Hopman Wim P M; Oyen Wim J G; Drenth Joost P H
Gastroparesis in patients with inactive Crohn's disease: a case series.
BMC gastroenterology 2007;7():11.
2006: Gotthardt Martin; Béhé Martin P; Grass Julia; Bauhofer Artur; Rinke Anja; Schipper Meike L; Kalinowski Marc; Arnold Rudolf; Oyen Wim J G; Behr Thomas M
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
Endocrine-related cancer 2006;13(4):1203-11.
2006: Dijkgraaf Ingrid; Kruijtzer John A W; Frielink Cathelijne; Soede Annemieke C; Hilbers Hans W; Oyen Wim J G; Corstens Frans H M; Liskamp Rob M J; Boerman Otto C
Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
Nuclear medicine and biology 2006;33(8):953-61.
2006: Koppe Manuel J; Hendriks Thijs; Boerman Otto C; Oyen Wim J G; Bleichrodt Robert P
Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(11):1867-74.
2006: de Geus-Oei L F; Wiering B; Krabbe P F M; Ruers T J M; Punt C J A; Oyen W J G
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1650-5.
2006: van Eerd Julliëtte E M; de Geus-Oei Lioe-Fee; Oyen Wim J G; Corstens Frans H M; Boerman Otto C
Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody.
European journal of nuclear medicine and molecular imaging 2006;33(11):1266-72.
2006: Gotthardt Martin; Béhé Martin P; Beuter Daniela; Battmann Anke; Bauhofer Artur; Schurrat Tino; Schipper Meike; Pollum Halina; Oyen Wim J G; Behr Thomas M
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.
European journal of nuclear medicine and molecular imaging 2006;33(11):1273-9.
2006: Koppe Manuel J; Oyen Wim J G; Bleichrodt Robert P; Verhofstad Albert A; Goldenberg David M; Boerman Otto C
Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
Cancer biotherapy & radiopharmaceuticals 2006;21(5):506-14.
2006: Vos F J; Bleeker-Rovers C P; van Dijk A P J; Oyen W J G
Detection of pacemaker and lead infection with FDG-PET.
European journal of nuclear medicine and molecular imaging 2006;33(10):1245.
2006: Vogel Wouter V; van Dalen Jorn A; Oyen Wim J G
Adequate evaluation of image registration in hybrid PET/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1556; author reply 1557-8.
2006: Troost Esther G C; Laverman Peter; Kaanders Johannes H A M; Philippens Mariëlle; Lok Jasper; Oyen Wim J G; van der Kogel Albert J; Boerman Otto C; Bussink Johan
Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):157-64.
2006: Riksen Niels P; Zhou Zhigang; Oyen Wim J G; Jaspers Rogier; Ramakers Bart P; Brouwer Rene M H J; Boerman Otto C; Steinmetz Neil; Smits Paul; Rongen Gerard A
Caffeine prevents protection in two human models of ischemic preconditioning.
Journal of the American College of Cardiology 2006;48(4):700-7.
2006: Scharn Dirk M; Oyen Wim J G; Klemm Peter L; Verhofstad Albert A J; van der Vliet J Adam
Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts.
The Journal of surgical research 2006;134(2):182-9.
2006: Barentsz Jelle; Takahashi Satoru; Oyen Wim; Mus Roel; De Mulder Pieter; Reznek Rodney; Oudkerk Matthijs; Mali Wim
Commonly used imaging techniques for diagnosis and staging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(20):3234-44.
2006: de Geus-Oei Lioe-Fee; Kaanders Johannes H A M; Pop Luc A M; Corstens Frans H M; Oyen Wim J G
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(1):51-6.
2006: Bastiaannet Esther; Hoekstra Otto S; Oyen Wim J G; Jager Piet L; Wobbes Theo; Hoekstra Harald J
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Annals of surgical oncology 2006;13(7):919-26.
2006: Hendrickx Baudewijn W; Punt Cees J A; Boerman Otto C; Postema Ernst J; Oosterwijk Egbert; Mavridu Agapi; Corstens Frans H M; Oyen Wim J G
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250.
Cancer biotherapy & radiopharmaceuticals 2006;21(3):263-8.
2006: Vos F J; Bleeker-Rovers C P; Corstens F H M; Kullberg B J; Oyen W J G
FDG-PET for imaging of non-osseous infection and inflammation.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2006;50(2):121-30.
2006: de Geus-Oei Lioe-Fee; Visser Eric P; Krabbe Paul F M; van Hoorn Bas A; Koenders Emile B; Willemsen Antoon T; Pruim Jan; Corstens Frans H M; Oyen Wim J G
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):945-9.
2006: Vogel Wouter V; van Dalen Jorn A; Schinagl Dominic A X; Kaanders Johannes H A M; Huisman HenkJan; Corstens Frans H M; Oyen Wim J G
Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
Nuclear medicine communications 2006;27(6):515-9.
2006: Laverman Peter; de Vries I Jolanda M; Scharenborg Nicole M; de Boer Annemiek; Broekema Matthias; Oyen Wim J G; Figdor Carl G; Adema Gosse J; Boerman Otto C
Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination.
Nuclear medicine and biology 2006;33(4):453-8.
2006: Wensing Bart M; Vogel Wouter V; Marres Henri A M; Merkx Matthias A W; Postema Ernst J; Oyen Wim J G; van den Hoogen Frank J A
FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
The Laryngoscope 2006;116(5):809-13.
2006: de Geus-Oei Lioe-Fee; Pieters Gerlach F F M; Bonenkamp Johannes J; Mudde Aart H; Bleeker-Rovers Chantal P; Corstens Frans H M; Oyen Wim J G
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):770-5.
2006: Van Cann Ellen M; Oyen Wim J G; Koole Ron; Stoelinga Paul J W
Bone SPECT reduces the number of unnecessary mandibular resections in patients with squamous cell carcinoma.
Oral oncology 2006;42(4):409-14.
2006: van Eerd Julliëtte E M; Vegt Erik; Wetzels Jack F M; Russel Frans G M; Masereeuw Rosalinde; Corstens Frans H M; Oyen Wim J G; Boerman Otto C
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):528-33.
2006: Vegt Erik; Wetzels Jack F M; Russel Frans G M; Masereeuw Rosalinde; Boerman Otto C; van Eerd Juliette E; Corstens Frans H M; Oyen Wim J G
Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):432-6.
2006: van Kouwen Mariëtte C A; Drenth Joost P H; van Krieken J Han J M; van Goor Harry; Friederich Pieter; Oyen Wim J G; Nagengast Fokko M
Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.
European journal of nuclear medicine and molecular imaging 2006;33(3):270-4.
2006: van Kouwen Mariëtte C A; Laverman Peter; van Krieken J Han J M; Oyen Wim J G; Nagengast Fokko M; Drenth Joost P H
Noninvasive monitoring of colonic carcinogenesis: feasibility of [(18)F]FDG-PET in the azoxymethane model.
Nuclear medicine and biology 2006;33(2):245-8.
2006: Koppe Manuel J; Boerman Otto C; Oyen Wim J G; Bleichrodt Robert P
Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Annals of surgery 2006;243(2):212-22.
2006: Bastiaannet E; Oyen W J G; Meijer S; Hoekstra O S; Wobbes T; Jager P L; Hoekstra H J
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients.
The British journal of surgery 2006;93(2):243-9.
2006: Koppe Manuel J; Oyen Wim J G; Bleichrodt Robert P; Hendriks Thijs; Verhofstad Albert A; Goldenberg David M; Boerman Otto C
Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
Cancer immunology, immunotherapy : CII 2006;55(1):47-55.
2006: de Geus-Oei Lioe-Fee; Ruers Theo J M; Punt Cornelis J A; Leer Jan Willem; Corstens Frans H M; Oyen Wim J G
FDG-PET in colorectal cancer.
Cancer imaging : the official publication of the International Cancer Imaging Society 2006;6():S71-81.
2006: Gotthardt Martin; Dijkgraaf Ingrid; Boerman Otto C; Oyen Wim J G
Nuclear medicine imaging and therapy of neuroendocrine tumours.
Cancer imaging : the official publication of the International Cancer Imaging Society 2006;6():S178-84.
2006: Schinagl D A X; Kaanders J H A M; Oyen W J G
From anatomical to biological target volumes: the role of PET in radiation treatment planning.
Cancer imaging : the official publication of the International Cancer Imaging Society 2006;6():S107-16.
2006: Gotthardt M; Rubner C; Bauhofer A; Berce F; Oyen W J G; Goecke J; Pfestroff A; Schlieck A; Corstens F H; Béhé M; Behr T M
What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Nuklearmedizin. Nuclear medicine 2006;45(5):206-12.
2005: Tan Edward C T H; Oyen Wim J G; Goris R Jan A
Leukocytes in Complex Regional Pain Syndrome type I.
Inflammation 2005;29(4-6):182-6.
2005: Koppe Manuel J; Postema Ernst J; Aarts Frits; Oyen Wim J G; Bleichrodt Robert P; Boerman Otto C
Antibody-guided radiation therapy of cancer.
Cancer metastasis reviews 2005;24(4):539-67.
2005: Brouwers Adrienne H; Boerman Otto C; Oyen Wim J G
In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8886; author reply 8886.
2005: Bleeker-Rovers Chantal P; Vos Fidel J; Wanten Geert J A; van der Meer Jos W M; Corstens Frans H M; Kullberg Bart-Jan; Oyen Wim J G
18F-FDG PET in detecting metastatic infectious disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2014-9.
2005: Wiering Bastiaan; Krabbe Paul F M; Jager Gerrit J; Oyen Wim J G; Ruers Theo J M
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Cancer 2005;104(12):2658-70.
2005: Hendrickx Baudewijn W; van Herpen Carla M L; Bonenkamp Johannes J; Bulten Johannes; Oyen Wim J G
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 1. Mediastinal sarcoidosis in a melanoma patient treated with interferon.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8906-7.
2005: Joosten J; Jager G; Oyen W; Wobbes Th; Ruers T
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(10):1152-9.
2005: de Vries I Jolanda M; Lesterhuis W Joost; Barentsz Jelle O; Verdijk Pauline; van Krieken J Han; Boerman Otto C; Oyen Wim J G; Bonenkamp Johannes J; Boezeman Jan B; Adema Gosse J; Bulte Jeff W M; Scheenen Tom W J; Punt Cornelis J A; Heerschap Arend; Figdor Carl G
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.
Nature biotechnology 2005;23(11):1407-13.
2005: Landheer M L E A; Steffens M G; Klinkenbijl J H G; Westenberg A H; Oyen W J G
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
The British journal of surgery 2005;92(11):1363-7.
2005: Vogel Wouter V; Wensing Bart M; van Dalen Jorn A; Krabbe Paul F M; van den Hoogen Frank J A; Oyen Wim J G
Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
European journal of nuclear medicine and molecular imaging 2005;32(11):1276-82.
2005: Kösters K; Bleeker-Rovers C P; van Crevel R; Oyen W J G; van der Ven A J A M
Aortitis diagnosed by F-18-fluorodeoxyglucose positron emission tomography in a patient with syphilis and HIV coinfection.
Infection 2005;33(5-6):387-9.
2005: Brouwers Adrienne H; Buijs Wilhelmina C A M; Mulders Peter F A; de Mulder Pieter H M; van den Broek Wim J M; Mala Carola; Oosterwijk Egbert; Boerman Otto C; Corstens Frans H M; Oyen Wim J G
Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7178s-7186s.
2005: Broekema Matthias; van Eerd Julliëtte J E M; Oyen Wim J G; Corstens Frans H M; Liskamp Rob M J; Boerman Otto C; Harris Thomas D
Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Journal of medicinal chemistry 2005;48(20):6442-53.
2005: van Laarhoven Hanneke W M; de Geus-Oei Lioe-Fee; Wiering Bastiaan; Lok Jasper; Rijpkema Mark; Kaanders Johannes H A M; Krabbe Paul F M; Ruers Theo; Punt Cornelis J A; van der Kogel Albert J; Oyen Wim J G; Heerschap Arend
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
Radiology 2005;237(1):181-8.
2005: Brouwers Adrienne H; Mulders Peter F A; de Mulder Pieter H M; van den Broek Wim J M; Buijs Wilhelmina C A M; Mala Carola; Joosten Frank B M; Oosterwijk Egbert; Boerman Otto C; Corstens Frans H M; Oyen Wim J G
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6540-8.
2005: van Eerd Julliëtte E M; Broekema Matthias; Harris Thomas D; Edwards D Scott; Oyen Wim J G; Corstens Frans H M; Boerman Otto C
Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(9):1546-51.
2005: Riksen Niels P; Oyen Wim J G; Ramakers Bart P; Van den Broek Petra H H; Engbersen Richard; Boerman Otto C; Smits Paul; Rongen Gerard A
Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans.
Clinical pharmacology and therapeutics 2005;78(1):52-9.
2005: van Kouwen Mariëtte C A; Laverman Peter; van Krieken J Han; Oyen Wim J G; Jansen Jan B M J; Drenth Joost P H
FDG-PET in the detection of early pancreatic cancer in a BOP hamster model.
Nuclear medicine and biology 2005;32(5):445-50.
2005: Kok Peter J M; van Eerd Juliëtte E M; Boerman Otto C; Corstens Frans H M; Oyen Wim J G
Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection.
Cancer biotherapy & radiopharmaceuticals 2005;20(3):310-5.
2005: van Kouwen Mariëtte C A; Nagengast Fokko M; Jansen Jan B M J; Oyen Wim J G; Drenth Joost P H
2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3713-7.
2005: Bleeker-Rovers C P; Warris A; Drenth J P H; Corstens F H M; Oyen W J G; Kullberg B-J
Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(6):493-5.
2005: van Eerd Julliëtte E M; Oyen Wim J G; Harris Thomas D; Rennen Huub J J M; Edwards D Scott; Corstens Frans H M; Boerman Otto C
Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):786-93.
2005: van Kouwen Mariëtte C A; Jansen Jan B M J; van Goor Harry; de Castro Steve; Oyen Wim J G; Drenth Joost P H
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.
European journal of nuclear medicine and molecular imaging 2005;32(4):399-404.
2005: van Schaijk Frank G; Oosterwijk Egbert; Molkenboer-Kuenen Janneke D; Soede Annemieke C; McBride Bill J; Goldenberg David M; Oyen Wim J G; Corstens Frans H M; Boerman Otto C
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(3):495-501.
2005: Koppe M J; Bleichrodt R P; Oyen W J G; Boerman O C
Radioimmunotherapy and colorectal cancer.
The British journal of surgery 2005;92(3):264-76.
2005: Vogel Wouter V; van Dalen Jorn A; Huisman Henkjan; Oyen Wim J G; Karssemeijer Nico
Sliced alternating DICOM series: convenient visualisation of image fusion on PACS.
European journal of nuclear medicine and molecular imaging 2005;32(2):247-8.
2005: Peeters Charlotte F J M; de Geus Lioe-Fee; Westphal Johan R; de Waal Robert M W; Ruiter Dirk J; Wobbes Theo; Oyen Wim J G; Ruers Theo J
Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.
Surgery 2005;137(2):246-9.
2005: Oyen Wim J G; Corstens Frans H M; Boerman Otto C
Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem?
European journal of nuclear medicine and molecular imaging 2005;32(2):151-2.
2005: Rongen Gerard A; Oyen Wim J G; Ramakers Bart P; Riksen Niels P; Boerman Otto C; Steinmetz Neil; Smits Paul
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Circulation 2005;111(2):173-8.
2005: de Groot Michel; Meeuwis Antoi P W; Kok Peter J M; Corstens Frans H M; Oyen Wim J G
Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.
European journal of nuclear medicine and molecular imaging 2005;32(1):98-101.
2005: Vogel Wouter V; Wiering Bastiaan; Corstens Frans H M; Ruers Theo J M; Oyen Wim J G
Colorectal cancer: the role of PET/CT in recurrence.
Cancer imaging : the official publication of the International Cancer Imaging Society 2005;5 Spec No A():S143-9.
2004: van Dalen J A; Vogel W; Huisman H J; Oyen W J G; Jager G J; Karssemeijer N
Accuracy of rigid CT-FDG-PET image registration of the liver.
Physics in medicine and biology 2004;49(23):5393-405.
2004: Bleeker-Rovers Chantal P; van der Ven André J; Zomer Bert; de Geus-Oei Lioe-Fee; Smits Paul; Corstens Frans H M; Koopmans Peter P; Oyen Wim J G
F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients.
AIDS (London, England) 2004;18(18):2430-2.
2004: Rennen Huub J J M; Bleeker-Rovers Chantal P; van Eerd Julliëtte E M; Frielink Cathelijne; Oyen Wim J G; Corstens Frans H M; Boerman Otto C
99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections.
Chest 2004;126(6):1954-61.
2004: van Kouwen Mariette C A; Drenth Joost P H; Oyen Wim J G; de Bruin Joyce H F M; Ligtenberg Marjolijn J; Bonenkamp J J Han; van Krieken J Han J M; Nagengast Fokko M
[18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6456-9.
2004: van Eerd Julliëtte E M; Rennen Huub J J M; Oyen Wim J G; Harris Thomas D; Edwards D Scott; Corstens Frans H M; Boerman Otto C
Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1747-53.
2004: Bleeker-Rovers Chantal P; Corstens Frans H M; Van Der Meer Jos W M; Oyen Wim J G
Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.
European journal of nuclear medicine and molecular imaging 2004;31(9):1342-3; author reply 1344.
2004: Brouwers Adrienne; Mulders Peter; Oosterwijk Egbert; Buijs Wilhelmina; Corstens Frans; Boerman Otto; Oyen Wim
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):466-77.
2004: de Geus-Oei Lioe-Fee; van Eerd-Vismale Julliëtte; Molthoff Carla; Corstens Frans; Oyen Wim; Boerman Otto
Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):457-65.
2004: Janssen Marcel; Frielink Cathelijne; Dijkgraaf Ingrid; Oyen Wim; Edwards D Scott; Liu Shuang; Rajopadhye Milind; Massuger Leon; Corstens Frans; Boerman Otto
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):399-404.
2004: Spermon J R; Oyen W J G; Strijk S P; Hulsbergen-van de Kaa C A; Witjes J A
Solitary skull recurrence from stage I seminomatous germ cell tumor of testis.
Urology 2004;64(2):377-9.
2004: Wiering Bastiaan; Ruers Theo J M; Oyen Wim J G
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
Expert review of anticancer therapy 2004;4(4):607-13.
2004: Oyen Wim J G; Bussink Jan; Verhagen Ad F T; Corstens Frans H M; Bootsma Gerben P
Role of FDG-PET in the diagnosis and management of lung cancer.
Expert review of anticancer therapy 2004;4(4):561-7.
2004: Koppe Manuel J; Bleichrodt Robert P; Soede Annemieke C; Verhofstad Albert A; Goldenberg David M; Oyen Wim J G; Boerman Otto C
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1224-32.
2004: Rennen Huub J J M; Frielink Cathelijne; Brandt Ernst; Zaat Sebastian A J; Boerman Otto C; Oyen Wim J G; Corstens Frans H M
Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1217-23.
2004: Hartman Ed H M; Pikkemaat Jeroen A; Van Asten Jacques J; Vehof Johan W M; Heerschap Arend; Oyen Wim J G; Spauwen Paul H M; Jansen John A
Demineralized bone matrix-induced ectopic bone formation in rats: in vivo study with follow-up by magnetic resonance imaging, magnetic resonance angiography, and dual-energy X-ray absorptiometry.
Tissue engineering 2004;10(5-6):747-54.
2004: Verhagen A F; Bollen E; Tjan-Heijnen V C; Bootsma G P; Hensens A; Oyen W J
[The biopsying of at least 5 mediastinal lymph node stations for presurgical staging in patients with a non-small-cell lung carcinoma]
Nederlands tijdschrift voor geneeskunde 2004;148(18):908; author reply 908-9.
2004: Laverman Peter; Béhé Martin; Oyen Wim J G; Willems Peter H G M; Corstens Frans H M; Behr Thomas M; Boerman Otto C
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
Bioconjugate chemistry 2004;15(3):561-8.
2004: Verhagen A F T; Bootsma G P; Tjan-Heijnen V C G; van der Wilt G J; Cox A L; Brouwer M H J; Corstens F H M; Oyen W J G
FDG-PET in staging lung cancer: how does it change the algorithm?
Lung cancer (Amsterdam, Netherlands) 2004;44(2):175-81.
2004: Brouwers Adrienne; Verel Iris; Van Eerd Julliëtte; Visser Gerard; Steffens Martijn; Oosterwijk Egbert; Corstens Frans; Oyen Wim; Van Dongen Guus; Boerman Otto
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):155-63.
2004: Bleeker-Rovers C P; Jager G; Tack C J; Van Der Meer J W M; Oyen W J G
F-18-fluorodeoxyglucose positron emission tomography leading to a diagnosis of septic thrombophlebitis of the portal vein: description of a case history and review of the literature.
Journal of internal medicine 2004;255(3):419-23.
2004: Brouwers Adrienne H; van Eerd Julliëtte E M; Frielink Cathelijne; Oosterwijk Egbert; Oyen Wim J G; Corstens Frans H M; Boerman Otto C
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(2):327-37.
2004: Vogel Wouter V; Oyen Wim J G; Barentsz Jelle O; Kaanders Johannes H A M; Corstens Frans H M
PET/CT: panacea, redundancy, or something in between?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45 Suppl 1():15S-24S.
2004: van Eerd Julliëtte E M; Laverman Peter; Oyen Wim J G; Harris Thomas D; Edwards D Scott; Ellars Charles E; Corstens Frans H M; Boerman Otto C
Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):89-93.
2004: Bleeker-Rovers Chantal P; Bredie Sebastian J H; van der Meer Jos W M; Corstens Frans H M; Oyen Wim J G
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
The American journal of medicine 2004;116(1):50-3.
2004: Bleeker-Rovers Chantal P; de Kleijn Elisabeth M H A; Corstens Frans H M; van der Meer Jos W M; Oyen Wim J G
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
European journal of nuclear medicine and molecular imaging 2004;31(1):29-37.
2004: van Kouwen M C A; Oyen W J G; Nagengast F M; Jansen J B M J; Drenth J P H
FDG-PET scanning in the diagnosis of gastrointestinal cancers.
Scandinavian journal of gastroenterology. Supplement 2004;(241):85-92.
2004: Gotthardt M; Boermann O C; Behr T M; Béhé M P; Oyen W J G
Development and clinical application of peptide-based radiopharmaceuticals.
Current pharmaceutical design 2004;10(24):2951-63.
2004: Bleeker-Rovers C P; Boerman O C; Rennen H J J M; Corstens F H M; Oyen W J G
Radiolabeled compounds in diagnosis of infectious and inflammatory disease.
Current pharmaceutical design 2004;10(24):2935-50.
2004: Berger Hans J C; Cools Alexander R; Horstink Martin W I M; Oyen Wim J G; Verhoeven Elisabeth W M; van der Werf Sieberen P
Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study.
Neuropsychologia 2004;42(8):1071-8.
2003: van Eerd J E M; Boerman O C; Corstens F H M; Oyen W J G
Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2003;47(4):246-55.
2003: Oyen Wim J G; Mansi Luigi
FDG-PET in infectious and inflammatory disease.
European journal of nuclear medicine and molecular imaging 2003;30(11):1568-70.
2003: Bleeker-Rovers C P; Bredie S J H; van der Meer J W M; Corstens F H M; Oyen W J G
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.
The Netherlands journal of medicine 2003;61(10):323-9.
2003: Postema Ernst J; Buijs Wilhelmina C A M; Boerman Otto C; Oyen Wim J G
Underestimation of absorbed dose to kidney.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(10):1707-8.
2003: Postema Ernst J; Börjesson Pontus K E; Buijs Wilhelmina C A M; Roos Jan C; Marres Henri A M; Boerman Otto C; de Bree Remco; Lang Margreet; Munzert Gerd; van Dongen Guus A M S; Oyen Wim J G
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(10):1690-9.
2003: Havenga K; Cobben D C P; Oyen W J G; Nienhuijs S; Hoekstra H J; Ruers T J M; Wobbes Th
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(8):662-4.
2003: Eggert Andreas A O; van der Voort Robbert; Torensma Ruurd; Moulin Veronique; Boerman Otto C; Oyen Wim J G; Punt C J A; Diepstra Heleen; de Boer Annemiek J; Figdor Carl G; Adema Gosse J
Analysis of dendritic cell trafficking using EGFP-transgenic mice.
Immunology letters 2003;89(1):17-24.
2003: Koppe Manuel J; Soede Annemieke C; Pels Wikke; Oyen Wim J G; Goldenberg David M; Bleichrodt Robert P; Boerman Otto C
Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin.
International journal of cancer. Journal international du cancer 2003;106(6):965-72.
2003: Janssen M L; Pels W; Massuger L F; Oyen W J; Boonstra H; Corstens F H; Boerman O C
Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(5):607-13.
2003: Postema Ernst J; Raemaekers John M M; Oyen Wim J G; Boerman Otto C; Mandigers Caroline M P W; Goldenberg David M; van Dongen Guus A M S; Corstens Frans H M
Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3995S-4002S.
2003: Börjesson Pontus K E; Postema Ernst J; Roos Jan C; Colnot David R; Marres Henri A M; van Schie Mathijs H; Stehle Gerd; de Bree Remco; Snow Gordon B; Oyen Wim J G; van Dongen Guus A M S
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3961S-72S.
2003: Brouwers Adrienne H; Buijs Wilhelmina C A M; Oosterwijk Egbert; Boerman Otto C; Mala Carola; De Mulder Pieter H M; Corstens Frans H M; Mulders Peter F A; Oyen Wim J G
Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3953S-60S.
2003: van Schaijk Frank G; Oosterwijk Egbert; Soede Annemiele C; Oyen Wim J G; McBride William J; Griffiths Gary L; Goldenberg David M; Corstens Frans H M; Boerman Otto C
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3880S-5S.
2003: Rennen Huub J J M; Boerman Otto C; Oyen Wim J G; Corstens Frans H M
Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(9):1502-9.
2003: Barrera P; Oyen W J G; Boerman O C; van Riel P L C M
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(9):825-8.
2003: Brouwers Adrienne H; Frielink Cathelijne; Oosterwijk Egbert; Oyen Wim J G; Corstens Frans H M; Boerman Otto C
Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):539-47.
2003: Postema Ernst J; Frielink Cathelijne; Oyen Wim J G; Raemaekers John M M; Goldenberg David M; Corstens Frans H M; Boerman Otto C
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):525-33.
2003: van den Hoogen F J; Oyen W J
[Diagnostic image (149). A woman with a mass at the base of the tongue. Lingual thyroid]
Nederlands tijdschrift voor geneeskunde 2003;147(30):1455.
2003: van Eerd Julliëtte E M; Oyen Wim J G; Harris Thomas D; Rennen Huub J J M; Edwards D Scott; Liu Shuang; Ellars Charles E; Corstens Frans H M; Boerman Otto C
A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(7):1087-91.
2003: Brouwers Frederieke M; Oyen Wim J G; Boerman Otto C; Barrett John A; Verheugt Freek W A; Corstens Frans H M; Van der Meer Jos W M
Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis.
Clinical nuclear medicine 2003;28(6):480-4.
2003: Bleeker-Rovers Chantal P; de Sévaux Ruud G L; van Hamersvelt Henk W; Corstens Frans H M; Oyen Wim J G
Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(6):E18-21.
2003: Postema Ernst J; Oyen Wim J G; Boerman Otto C; Corstens Frans H M
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):853.
2003: Rennen H J; Oyen W J; Cain S A; Monk P N; Corstens F H; Boerman O C
Tc-99m-labeled C5a and C5a des Arg74 for infection imaging.
Nuclear medicine and biology 2003;30(3):267-72.
2003: Jager P L; Slart R H J A; Corstens F; Oyen W J G; Hoekstra O; Teule J
PET-CT: a matter of opinion?
European journal of nuclear medicine and molecular imaging 2003;30(3):470-1; author reply 471.
2003: Stikkelbroeck Nike M M L; Oyen Wim J G; van der Wilt Gert-Jan; Hermus Ad R M M; Otten Barto J
Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.
The Journal of clinical endocrinology and metabolism 2003;88(3):1036-42.
2003: Boerman Otto C; van Schaijk Frank G; Oyen Wim J G; Corstens Frans H M
Pretargeted radioimmunotherapy of cancer: progress step by step.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(3):400-11.
2003: den Broeder Alfons A; Wanten Geert J A; Oyen Wim J G; Naber Ton; van Riel Piet L C M; Barrera Pilar
Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis.
The Journal of rheumatology 2003;30(2):232-7.
2003: Hoogendoorn E H; Oyen W J G; van Dijk A P J; van der Meer J W M
Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(1):73-6.
2003: De Vries I Jolanda M; Krooshoop Daniëlle J E B; Scharenborg Nicole M; Lesterhuis W Joost; Diepstra J Heleen S; Van Muijen Goos N P; Strijk Simon P; Ruers Theo J; Boerman Otto C; Oyen Wim J G; Adema Gosse J; Punt Cornelis J A; Figdor Carl G
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.
Cancer research 2003;63(1):12-7.
2002: Janssen Marcel; Oyen Wim J G; Massuger Leon F A G; Frielink Cathelijne; Dijkgraaf Ingrid; Edwards D Scott; Radjopadhye Milind; Corstens Frans H M; Boerman Otto C
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):641-6.
2002: Scharn Dirk M; Oyen Wim J G; Klemm Peter L; Wijnen Marc H W A; vanderVliet J Adam
Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model.
Cardiovascular surgery (London, England) 2002;10(6):566-9.
2002: Langenhoff B S; Oyen W J G; Jager G J; Strijk S P; Wobbes Th; Corstens F H M; Ruers T J M
Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4453-8.
2002: Janssen Marcel L; Oyen Wim J; Dijkgraaf Ingrid; Massuger Leon F; Frielink Cathelijne; Edwards D Scott; Rajopadhye Milind; Boonstra Henk; Corstens Frans H; Boerman Otto C
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Cancer research 2002;62(21):6146-51.
2002: Steffens M G; Mulders P F A; Brouwers A H; Oyen W J G
Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
The Journal of urology 2002;168(5):2127-8.
2002: Gratz Stefan; Rennen Huub J J M; Boerman Otto C; Oyen Wim J G; Mast Peter; Behr Thomas M; Corstens Frans H M
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(7):918-24.
2002: Laverman Peter; Boerman Otto C; Corstens Frans H M; Oyen Wim J G
Fluorinated amino acids for tumour imaging with positron emission tomography.
European journal of nuclear medicine and molecular imaging 2002;29(5):681-90.
2002: Spermon J R; De Geus-Oei L F; Kiemeney L A L M; Witjes J A; Oyen W J G
The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
BJU international 2002;89(6):549-56.
2002: Rennen Huub J J M; van Eerd Julliëtte E; Oyen Wim J G; Corstens Frans H M; Edwards D Scott; Boerman Otto C
Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.
Bioconjugate chemistry 2002;13(2):370-7.
2002: Brouwers A H; Dorr U; Lang O; Boerman O C; Oyen W J G; Steffens M G; Oosterwijk E; Mergenthaler H G; Bihl H; Corstens F H M
131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.
Nuclear medicine communications 2002;23(3):229-36.
2002: Laverman P; Boerman O C; Storm G; Oyen W J G
(99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumours.
British journal of cancer 2002;86(4):659-61.
2002: Becker Martin J; Dams Els Th M; de Marie Siem; Oyen Wim J G; Boerman Otto C; Fens Marcel H A M; Verbrugh Henri A; Bakker-Woudenberg Irma A J M
Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats.
Nuclear medicine and biology 2002;29(2):177-84.
2002: Ruers T J M; Langenhoff B S; Neeleman N; Jager G J; Strijk S; Wobbes Th; Corstens F H M; Oyen W J G
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):388-95.
2001: Drenth J P; Nagengast F M; Oyen W J
Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.
European journal of nuclear medicine 2001;28(12):1766-9.
2001: Postema E J; Boerman O C; Oyen W J; Raemaekers J M; Corstens F H
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
European journal of nuclear medicine 2001;28(11):1725-35.
2001: Oyen W J; Boerman O C; Corstens F H
Animal models of infection and inflammation and their role in experimental nuclear medicine.
Journal of microbiological methods 2001;47(2):151-7.
2001: Boerman O C; Rennen H; Oyen W J; Corstens F H
Radiopharmaceuticals to image infection and inflammation.
Seminars in nuclear medicine 2001;31(4):286-95.
2001: Oyen W J; Witjes J A; Corstens F H
Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma.
European urology 2001;40(3):294-9.
2001: Boerman O C; van Eerd J; Oyen W J; Corstens F H
A 3-step pretargeting strategy to image infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(9):1405-11.
2001: Mollen R M; Hopman W P; Oyen W J; Kuijpers H H; Edelbroek M A; Jansen J B
Effect of subtotal colectomy on gastric emptying of a solid meal in slow-transit constipation.
Diseases of the colon and rectum 2001;44(8):1189-95.
2001: Laverman P; Dams E T; Storm G; Hafmans T G; Croes H J; Oyen W J; Corstens F H; Boerman O C
Microscopic localization of PEG-liposomes in a rat model of focal infection.
Journal of controlled release : official journal of the Controlled Release Society 2001;75(3):347-55.
2001: Gratz S; Rennen H J; Boerman O C; Oyen W J; Burma P; Corstens F H
(99m)Tc-interleukin-8 for imaging acute osteomyelitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(8):1257-64.
2001: Boerman O C; Oyen W J; Corstens F H
Progress in gene therapy: seeing is believing.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(8):1235-7.
2001: Laverman P; Carstens M G; Boerman O C; Dams E T; Oyen W J; van Rooijen N; Corstens F H; Storm G
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
The Journal of pharmacology and experimental therapeutics 2001;298(2):607-12.
2001: Rennen H J; Corstens F H; Oyen W J; Boerman O C
New concepts in infection/inflammation imaging.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2001;45(2):167-73.
2001: Gratz S; Rennen H J; Boerman O C; Oyen W J; Corstens F H
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):917-23.
2001: Rennen H J; Makarewicz J; Oyen W J; Laverman P; Corstens F H; Boerman O C
The effect of molecular weight on nonspecific accumulation of (99m)T-labeled proteins in inflammatory foci.
Nuclear medicine and biology 2001;28(4):401-8.
2001: Stearne L E; Gyssens I C; Goessens W H; Mouton J W; Oyen W J; van der Meer J W; Verbrugh H A
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Antimicrobial agents and chemotherapy 2001;45(5):1394-401.
2001: Rennen H J; Boerman O C; Oyen W J; Corstens F H
Imaging infection/inflammation in the new millennium.
European journal of nuclear medicine 2001;28(2):241-52.
2001: Boerman O C; Dams E T; Oyen W J; Corstens F H; Storm G
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2001;50(2):55-64.
2001: Rennen H J; Boerman O C; Oyen W J; van der Meer J W; Corstens F H
Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(1):117-23.
2000: Brouwers A H; Laverman P; Boerman O C; Oyen W J; Barrett J A; Harris T D; Edwards D S; Corstens F H
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits.
Nuclear medicine communications 2000;21(11):1043-50.
2000: Vogels O J; Veltman J; Oyen W J; Horstink M W
Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration.
Journal of the neurological sciences 2000;180(1-2):62-5.
2000: Boerman O C; Laverman P; Oyen W J; Corstens F H; Storm G
Radiolabeled liposomes for scintigraphic imaging.
Progress in lipid research 2000;39(5):461-75.
2000: Rennen H J; Boerman O C; Koenders E B; Oyen W J; Corstens F H
Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction.
Nuclear medicine and biology 2000;27(6):599-604.
2000: Barrera P; van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; van Lent P L; van de Putte L B; Corstens F H
Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39(8):870-4.
2000: Boerman O C; Oyen W J; Corstens F H
Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
Seminars in nuclear medicine 2000;30(3):195-208.
2000: Laverman P; Brouwers A H; Dams E T; Oyen W J; Storm G; van Rooijen N; Corstens F H; Boerman O C
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.
The Journal of pharmacology and experimental therapeutics 2000;293(3):996-1001.
2000: Corvo M L; Boerman O C; Oyen W J; Jorge J C; Cruz M E; Crommelin D J; Storm G
Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model.
Pharmaceutical research 2000;17(5):600-6.
2000: Laverman P; Zalipsky S; Oyen W J; Dams E T; Storm G; Mullah N; Corstens F H; Boerman O C
Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):912-8.
2000: Dams E T; Nijhof M W; Boerman O C; Laverman P; Storm G; Buma P; Lemmens J A; van der Meer J W; Corstens F H; Oyen W J
Scintigraphic evaluation of experimental chronic osteomyelitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):896-902.
2000: Oyen W J; Boerman O C; Brouwers F M; Barrett J A; Verheugt F W; Ruiter D J; Corstens F H; van der Meer J W
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444.
European journal of nuclear medicine 2000;27(4):392-9.
2000: Oyen W J; Verhagen C; Saris E; van den Broek W J; Pieters G F; Corsten F H
Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):643-6.
2000: Dams E T; Oyen W J; Boerman O C; Storm G; Laverman P; Kok P J; Buijs W C; Bakker H; van der Meer J W; Corstens F H
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):622-30.
2000: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; van der Meer J W; Corstens F H
Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(3):463-9.
2000: Dams E T; Laverman P; Oyen W J; Storm G; Scherphof G L; van Der Meer J W; Corstens F H; Boerman O C
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
The Journal of pharmacology and experimental therapeutics 2000;292(3):1071-9.
2000: Brouwers A H; De Jong D J; Dams E T; Oyen W J; Boerman O C; Laverman P; Naber T H; Storm G; Corstens F H
Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn's disease.
Journal of drug targeting 2000;8(4):225-33.
1999: Dams E T; Becker M J; Oyen W J; Boerman O C; Storm G; Laverman P; de Marie S; van der Meer J W; Bakker-Woudenberg I A; Corstens F H
Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2066-72.
1999: Steffens M G; Boerman O C; de Mulder P H; Oyen W J; Buijs W C; Witjes J A; van den Broek W J; Oosterwijk-Wakka J C; Debruyne F M; Corstens F H; Oosterwijk E
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3268s-3274s.
1999: Boerman O C; Kranenborg M H; Oosterwijk E; Griffiths G L; McBride W J; Oyen W J; de Weijert M; Oosterwijk-Wakka J; Hansen H J; Corstens F H
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.
Cancer research 1999;59(17):4400-5.
1999: Eggert A A; Schreurs M W; Boerman O C; Oyen W J; de Boer A J; Punt C J; Figdor C G; Adema G J
Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
Cancer research 1999;59(14):3340-5.
1999: Corvo M L; Boerman O C; Oyen W J; Van Bloois L; Cruz M E; Crommelin D J; Storm G
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis.
Biochimica et biophysica acta 1999;1419(2):325-34.
1999: Dams E T; Reijnen M M; Oyen W J; Boerman O C; Laverman P; Storm G; van der Meer J W; Corstens F H; van Goor H
Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG.
Annals of surgery 1999;229(4):551-7.
1999: Steffens M G; Boerman O C; Oyen W J; Kniest P H; Witjes J A; Oosterhof G O; van Leenders G J; Debruyne F M; Corstens F H; Oosterwijk E
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.
Cancer research 1999;59(7):1615-9.
1999: van der Laan L; Oyen W J; Tan E C; Verhofstad A A; Hendriks T; Goris R J
A comparison of free radical-induced vascular and skeletal muscle damage in immunocompetent and neutropenic rats.
The Journal of surgical research 1999;82(2):346-52.
1999: Laverman P; Dams E T; Oyen W J; Storm G; Koenders E B; Prevost R; van der Meer J W; Corstens F H; Boerman O C
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):192-7.
1998: Boerman O C; Oyen W J; Corstens F H; Storm G
Liposomes for scintigraphic imaging: optimization of in vivo behavior.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(4):271-9.
1998: Dams E T; Oyen W J; Boerman O C; Storm G; Laverman P; Koenders E B; van der Meer J W; Corstens F H
Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2172-8.
1998: Buijs W C; Oyen W J; Dams E T; Boerman O C; Siegel J A; Claessens R A; van der Meer J W; Corstens F H
Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
Nuclear medicine communications 1998;19(8):743-51.
1998: van der Laken C J; Boerman O C; Oyen W J; Laverman P; van de Ven M T; Corstens F H; van der Meer J W
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
The Journal of infectious diseases 1998;177(5):1398-401.
1998: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; van der Meer J W; Corstens F H
Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
European journal of nuclear medicine 1998;25(5):535-46.
1998: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; van der Meer J W; Corstens F H
Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study.
European journal of nuclear medicine 1998;25(4):347-52.
1998: Van der Laken C J; Boerman O C; Oyen W J; Van de Ven M T; Ven der Meer J W; Corstens F H
The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation.
Nuclear medicine communications 1998;19(3):271-81.
1998: Dams E T; Oyen W J; Boerman O C; Claessens R A; Wymenga A B; van der Meer J W; Corstens F H
Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):119-24.
1998: Oyen W J; Raemaekers J M; Corstens F H
Acute myelofibrosis mimicking multiple bone metastases on Tc-99m MDP bone imaging.
Clinical nuclear medicine 1998;23(1):1-2.
1997: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Chizzonite R; Corstens F H; van der Meer J W
Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.
The Journal of clinical investigation 1997;100(12):2970-6.
1997: Oyen W J; Boerman O C; Dams E T; Storm G; van Bloois L; Koenders E B; van Haelst U J; van der Meer J W; Corstens F H
Scintigraphic evaluation of experimental colitis in rabbits.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1596-600.
1997: van der Laan L; Oyen W J; Verhofstad A A; Tan E C; ter Laak H J; Gabreels-Festen A; Hendriks T; Goris R J
Soft tissue repair capacity after oxygen-derived free radical-induced damage in one hindlimb of the rat.
The Journal of surgical research 1997;72(1):60-9.
1997: Nijhof M W; Oyen W J; van Kampen A; Claessens R A; van der Meer J W; Corstens F H
Hip and knee arthroplasty infection. In-111-IgG scintigraphy in 102 cases.
Acta orthopaedica Scandinavica 1997;68(4):332-6.
1997: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Edwards D S; Barrett J A; van der Meer J W; Corstens F H
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1310-5.
1997: Nijhof M W; Oyen W J; van Kampen A; Claessens R A; van der Meer J W; Corstens F H
Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1300-5.
1997: Boerman O C; Oyen W J; Storm G; Corvo M L; van Bloois L; van der Meer J W; Corstens F H
Technetium-99m labelled liposomes to image experimental arthritis.
Annals of the rheumatic diseases 1997;56(6):369-73.
1997: Kranenborg M H; Oyen W J; Corstens F H; Oosterwijk E; van der Meer J W; Boerman O C
Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):901-6.
1997: Steffens M G; Boerman O C; Oosterwijk-Wakka J C; Oosterhof G O; Witjes J A; Koenders E B; Oyen W J; Buijs W C; Debruyne F M; Corstens F H; Oosterwijk E
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1529-37.
1997: van der Laan L; Kapitein P J; Oyen W J; Verhofstad A A; Hendriks T; Goris R J
A novel animal model to evaluate oxygen derived free radical damage in soft tissue.
Free radical research 1997;26(4):363-72.
1997: Boerman O C; Oyen W J; van Bloois L; Koenders E B; van der Meer J W; Corstens F H; Storm G
Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):489-93.
1997: Nieuwenhuijzen G A; Knapen M F; Oyen W J; Hendriks T; Corstens F H; Goris R J
Organ damage is preceded by changes in protein extravasation in an experimental model of multiple organ dysfunction syndrome.
Shock (Augusta, Ga.) 1997;7(2):98-104.
1996: Perenboom R M; Beckers P; Van Der Meer J W; Van Schijndel A C; Oyen W J; Corstens F H; Sauerwein R W
Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats.
Journal of leukocyte biology 1996;60(6):710-5.
1996: Claessens R A; Koenders E B; Oyen W J; Corstens F H
Retention of technetium-99m in infectious foci in rats after release from technetium-99m labelled human non-specific polyclonal immunoglobulin G: a dual-label study with hydrazinonicotinamido and iminothiolano immunoglobulin.
European journal of nuclear medicine 1996;23(11):1536-9.
1996: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Claessens R A; van der Meer J W; Corstens F H
Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection.
European journal of nuclear medicine 1996;23(11):1531-5.
1996: Oyen W J; Boerman O C; Storm G; van Bloois L; Koenders E B; Crommelin D J; van der Meer J W; Corstens F H
Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy?
Nuclear medicine communications 1996;17(9):742-8.
1996: Oyen W J; Boerman O C; Storm G; van Bloois L; Koenders E B; Claessens R A; Perenboom R M; Crommelin D J; van der Meer J W; Corstens F H
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(8):1392-7.
1996: Oyen W J; Boerman O C; Subramanian R; Koenders E B; Claessens R A; van der Meer J W; Corstens F H
Biodistribution of 111In-labelled IgG and IgM in experimental infection.
Nuclear medicine communications 1996;17(7):616-20.
1996: Oyen W J; Boerman O C; van der Laken C J; van der Meer J W; Corstens F H
Macrophage targeting in experimental arthritis.
European journal of nuclear medicine 1996;23(6):727-9.
1996: Oyen W J; Boerman O C; van der Laken C J; Claessens R A; van der Meer J W; Corstens F H
The uptake mechanisms of inflammation- and infection-localizing agents.
European journal of nuclear medicine 1996;23(4):459-65.
1996: Claessens R A; Boerman O C; Koenders E B; Oyen W J; van der Meer J W; Corstens F H
Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.
European journal of nuclear medicine 1996;23(4):414-21.
1996: Oyen W J; Lemmens J A; Claessens R A; van Horn J R; Slooff T J; Corstens F H
Nuclear arthrography: combined scintigraphic and radiographic procedure for diagnosis of total hip prosthesis loosening.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):62-70.
1995: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Claessens R A; van der Meer J W; Corstens F H
Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model.
European journal of nuclear medicine 1995;22(11):1249-55.
1995: Oyen W J; van Oort A M; Tanke R B; van Mill G J; Aengevaeren W R; Corstens F H
Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(11):2006-8.
1995: Perenboom R M; Oyen W J; van Schijndel A C; Beckers P; Corstens F H; van der Meer J W
Serial indium-111-labelled IgG biodistribution in rat Pneumocystis carinii pneumonia: a tool to monitor the course and severity of the infection.
European journal of nuclear medicine 1995;22(10):1129-32.
1995: Boerman O C; Storm G; Oyen W J; van Bloois L; van der Meer J W; Claessens R A; Crommelin D J; Corstens F H
Sterically stabilized liposomes labeled with indium-111 to image focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(9):1639-44.
1995: Oyen W J; Corstens F H
Scintigraphic techniques for delineation of infection and inflammation.
British journal of hospital medicine 1995;54(2-3):75-80.
1995: van Oort A M; Tanke R B; Oyen W J; van Mill G J; Aengevaeren W R
[Endovascular stent in the treatment of residual pulmonary stenosis in patients operated on for congenital heart defects; initial results]
Nederlands tijdschrift voor geneeskunde 1995;139(23):1182-7.
1995: Oyen W J; Mudde A H; van den Broek W J; Corstens F H
Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(4):613-5.
1995: Claessens R A; Koenders E B; Boerman O C; Oyen W J; Borm G F; van der Meer J W; Corstens F H
Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci.
European journal of nuclear medicine 1995;22(3):212-9.
1994: Oyen W J; Boerman O C; Claessens R A; van der Meer J W; Corstens F H
Is somatostatin receptor scintigraphy suited to detection of acute infectious disease?
Nuclear medicine communications 1994;15(4):289-93.
1993: Oyen W J; Arntz I E; Claessens R M; Van der Meer J W; Corstens F H; Goris R J
Reflex sympathetic dystrophy of the hand: an excessive inflammatory response?
Pain 1993;55(2):151-7.
1993: Corstens F H; Oyen W J; Becker W S
Radioimmunoconjugates in the detection of infection and inflammation.
Seminars in nuclear medicine 1993;23(2):148-64.
1993: Oyen W J; Buijs W C; van Kampen A; Koenders E B; Claessens R A; Corstens F H
Intraoperative bone and bone marrow sampling: a simple method for accurate measurement of uptake of radiopharmaceuticals in bone and bone marrow.
Nuclear medicine communications 1993;14(2):112-6.
1992: Oyen W J; Netten P M; Lemmens J A; Claessens R A; Lutterman J A; van der Vliet J A; Goris R J; van der Meer J W; Corstens F H
Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(7):1330-6.
1992: Oyen W J; Claessens R A; van der Meer J W; Rubin R H; Strauss H W; Corstens F H
Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(5):1110-8.
1992: Oyen W J; Claessens R A; van der Meer J W; Corstens F H
Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(3):388-94.
1992: Oyen W J; Claessens R A; Raemaekers J M; de Pauw B E; van der Meer J W; Corstens F H
Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):61-8.
1992: Oyen W J; van Horn J R; Claessens R A; Slooff T J; van der Meer J W; Corstens F H
Diagnosis of bone, joint, and joint prosthesis infections with In-111-labeled nonspecific human immunoglobulin G scintigraphy.
Radiology 1992;182(1):195-9.
1991: Oyen W J; Claessens R A; van der Meer J W; Corstens F H
Detection of subacute infectious foci with indium-111-labeled autologous leukocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(10):1854-60.
1990: Oyen W J; Claessens R A; van Horn J R; van der Meer J W; Corstens F H
Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(4):403-12.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Wim Oyen

Research Profile (preview)

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Wim Oyen (preview)

All Publications